SEC Form D · filed February 19, 2026
Evogene Ltd
Offering
$3.4M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
REHOVOT, L3
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (9)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗